Sort   by:  
 Page size 
UnknownClearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia.
Not available
S-EPMC6008108 | biostudies-literature
UnknownImmuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial.
Not available
S-EPMC7661209 | biostudies-literature
UnknownSurvival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy.
Not available
S-EPMC7362563 | biostudies-literature
UnknownIdentification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study.
Not available
S-EPMC7906623 | biostudies-literature
UnknownOne-year mortality after ICU admission due to COVID-19 infection.
Not available
S-EPMC8764887 | biostudies-literature
UnknownGenetic evolution and relapse-associated mutations in adult T-cell acute lymphoblastic leukemia patients treated in PETHEMA trials.
Not available
S-EPMC12104817 | biostudies-literature
UnknownMechanical power is not associated with mortality in COVID-19 mechanically ventilated patients.
Not available
S-EPMC11861844 | biostudies-literature
UnknownHigh-flow nasal oxygen in patients with COVID-19-associated acute respiratory failure.
Not available
S-EPMC7876530 | biostudies-literature
UnknownMajor candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study.
Not available
S-EPMC9211796 | biostudies-literature
UnknownClinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS.
Not available
S-EPMC7387884 | biostudies-literature
Sort   by:  
 Page size